• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药用无机化学中麦芽酚及其类似物的金属配合物。

Metal complexes of maltol and close analogues in medicinal inorganic chemistry.

作者信息

Thompson Katherine H, Barta Cheri A, Orvig Chris

机构信息

Medicinal Inorganic Chemistry Group, Chemistry Department, University of British Columbia, Vancouver, BC, Canada V6T 1Z1.

出版信息

Chem Soc Rev. 2006 Jun;35(6):545-56. doi: 10.1039/b416256k. Epub 2006 Apr 12.

DOI:10.1039/b416256k
PMID:16729148
Abstract

The family of hydroxypyrones and close congeners, the hydroxypyridinones, is a particularly versatile class of ligands. The most widely investigated for medicinal applications are the 3-hydroxy-4-pyrones and the 1,2- 3,2- and 3,4-hydroxypyridinones. Key features of these ligands are: a six-membered ring, with a ring N or O atom either ortho or para to a ketone group, and two ortho exocyclic oxygen atoms. Readily functionalizable, the hydroxypyrones and hydroxypyridinones allow one to achieve a range of di- and trivalent metallocomplex stabilities and can include tissue or molecular targeting features by design. Research over the past several decades has greatly expanded the array of ligands that are the subject of this critical review. Ligand applications as diverse as iron removal or supplementation, contrast agents in imaging applications, and mobilization of undesirable excess metal ions will be surveyed herein.

摘要

羟基吡喃酮及其类似物羟基吡啶酮家族是一类特别通用的配体。在医学应用中研究最广泛的是3-羟基-4-吡喃酮以及1,2-、3,2-和3,4-羟基吡啶酮。这些配体的关键特征包括:一个六元环,环上的氮或氧原子与酮基处于邻位或对位,以及两个邻位的环外氧原子。羟基吡喃酮和羟基吡啶酮易于功能化,能够实现一系列二价和三价金属配合物的稳定性,并且可以通过设计包含组织或分子靶向特征。过去几十年的研究极大地扩展了作为本重要综述主题的配体种类。本文将概述配体在诸如铁去除或补充、成像应用中的造影剂以及去除不需要的过量金属离子等多种不同方面的应用。

相似文献

1
Metal complexes of maltol and close analogues in medicinal inorganic chemistry.药用无机化学中麦芽酚及其类似物的金属配合物。
Chem Soc Rev. 2006 Jun;35(6):545-56. doi: 10.1039/b416256k. Epub 2006 Apr 12.
2
Design of targeting ligands in medicinal inorganic chemistry.药物无机化学中靶向配体的设计。
Chem Soc Rev. 2006 Jun;35(6):534-44. doi: 10.1039/b514859f. Epub 2006 Apr 20.
3
Lanthanides in magnetic resonance imaging.磁共振成像中的镧系元素。
Chem Soc Rev. 2006 Jun;35(6):557-71. doi: 10.1039/b516376p. Epub 2006 May 2.
4
Prospects of metal complexes peripherally substituted with sugars in biomedicinal applications.糖类外周取代的金属配合物在生物医学应用中的前景。
Chemistry. 2009;15(7):1548-57. doi: 10.1002/chem.200802013.
5
Synthesis, structure and spectroscopy of new thiopyrone and hydroxypyridinethione transition-metal complexes.新型硫代吡喃酮和羟基吡啶硫酮过渡金属配合物的合成、结构与光谱学
Dalton Trans. 2005 Aug 7(15):2588-96. doi: 10.1039/b505034k. Epub 2005 Jun 23.
6
Lanthanide complexes based on a 1,7-diaza-12-crown-4 platform containing picolinate pendants: a new structural entry for the design of magnetic resonance imaging contrast agents.基于含吡啶甲酸侧基的1,7-二氮杂-12-冠-4平台的镧系配合物:磁共振成像造影剂设计的一种新结构类型。
Inorg Chem. 2008 Sep 1;47(17):7840-51. doi: 10.1021/ic800878x. Epub 2008 Aug 2.
7
Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes.钆(III)配合物作为磁共振成像造影剂:配体设计与配合物性质
Dalton Trans. 2008 Jun 21(23):3027-47. doi: 10.1039/b719704g. Epub 2008 Mar 27.
8
Lanthanide-transition metal coordination polymers based on multiple N- and O-donor ligands.基于多种含氮和含氧供体配体的镧系-过渡金属配位聚合物。
Chem Commun (Camb). 2006 Jan 14(2):135-43. doi: 10.1039/b509458p. Epub 2005 Nov 22.
9
Synthesis and coordination properties of trifluoromethyl decorated derivatives of 2,6-bis[(diphenylphosphinoyl)methyl]pyridine N-oxide ligands with lanthanide ions.2,6-双[(二苯基磷酰基)甲基]吡啶 N-氧化物配体的三氟甲基修饰衍生物与镧系离子的合成及配位性质
Inorg Chem. 2009 Apr 6;48(7):3104-13. doi: 10.1021/ic802390c.
10
Biologically relevant O,S-donor compounds. Synthesis, molybdenum complexation and xanthine oxidase inhibition.具有生物学相关性的氧、硫供体化合物。合成、钼络合及黄嘌呤氧化酶抑制作用。
Dalton Trans. 2008 Apr 7(13):1773-82. doi: 10.1039/b717172b. Epub 2008 Feb 20.

引用本文的文献

1
Study on the electrochemical and spectroscopic characteristics of holmium ion and its interaction with DNA.钬离子的电化学和光谱特性及其与 DNA 的相互作用研究。
Sci Rep. 2024 Sep 2;14(1):20383. doi: 10.1038/s41598-024-71412-4.
2
The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency.天然和合成螯合剂在医学中的重要性和必要性:有效治疗铁过载和缺铁症的前景增加。
Int J Mol Sci. 2024 Apr 25;25(9):4654. doi: 10.3390/ijms25094654.
3
Multipurpose Iron-Chelating Ligands Inspired by Bioavailable Molecules.
受生物可利用分子启发的多用途铁螯合剂。
Biomolecules. 2024 Jan 11;14(1):92. doi: 10.3390/biom14010092.
4
Deferiprone and Iron-Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects.地拉罗司和铁-麦芽酚:从发现到药物设计、研发、临床应用及未来前景的四十年。
Int J Mol Sci. 2023 Mar 4;24(5):4970. doi: 10.3390/ijms24054970.
5
Hydroxy-directed iridium-catalyzed enantioselective formal β-C(sp)-H allylic alkylation of α,β-unsaturated carbonyls.羟基导向的铱催化α,β-不饱和羰基化合物的对映选择性形式β-C(sp)-H烯丙基烷基化反应
Chem Sci. 2022 Oct 13;13(42):12491-12497. doi: 10.1039/d2sc03966d. eCollection 2022 Nov 2.
6
New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.使用三价麦芽酚铁和其他亲脂性铁螯合剂复合物治疗缺铁性贫血的新时代:发现的历史视角和未来应用。
Int J Mol Sci. 2021 May 24;22(11):5546. doi: 10.3390/ijms22115546.
7
Regulation of mGluR1 on the Expression of PKC and NMDAR in Aluminum-Exposed PC12 Cells.铝暴露 PC12 细胞中 mGluR1 对 PKC 和 NMDAR 表达的调节。
Neurotox Res. 2021 Jun;39(3):634-644. doi: 10.1007/s12640-020-00319-5. Epub 2021 Jan 19.
8
Antioxidant Properties of Lapachol and Its Derivatives and Their Ability to Chelate Iron (II) Cation: DFT and QTAIM Studies.拉帕醇及其衍生物的抗氧化特性及其螯合铁(II)阳离子的能力:密度泛函理论和量子拓扑原子理论研究
Bioinorg Chem Appl. 2020 Mar 31;2020:2103239. doi: 10.1155/2020/2103239. eCollection 2020.
9
Insights on the relationship between structure vs. toxicological activity of antibacterial rhodamine-labelled 3-hydroxy-4-pyridinone iron(III) chelators in HepG2 cells.关于抗菌罗丹明标记的3-羟基-4-吡啶酮铁(III)螯合剂在HepG2细胞中的结构与毒理学活性之间关系的见解。
Interdiscip Toxicol. 2018 Oct;11(3):189-199. doi: 10.2478/intox-2018-0016. Epub 2019 Oct 18.
10
MRI and fluorescence studies of Saccharomyces cerevisiae loaded with a bimodal Fe(III) T contrast agent.载双模态 Fe(III) T 造影剂的酿酒酵母的 MRI 和荧光研究。
J Inorg Biochem. 2019 Dec;201:110832. doi: 10.1016/j.jinorgbio.2019.110832. Epub 2019 Sep 6.